Cryosite Ltd (CTE)
20mins delayed
Movement
1 Year Return
Cryosite Ltd Chart
| Share price | |
| Last | |
| Change | |
| Volume | |
| Turnover | |
| Market Cap | $10.54 million |
| Today's Movement | |
| Prev. Close | |
| Open | |
| Day Range | - |
| VWAP | |
| Historical Stats | |
| 52w Range | - |
| 4w Avg Volume | |
| 4w Avg Turnover | |
| (delayed) | |
CTE Statistics
01 October
1,841 / 2,232
ASX Size Rank
1yr Return
vs Sector (1yr)
+392.60%
vs ASX 200 (1yr)
+422.92%
$10.54 million
Market Cap
Share Issue
46.86 million
All Ords (%)
N/A
Short Sold
0%
Current Fundamentals
01 October
7.1
PE Ratio
EPS ($)
0.032
Earnings Yield
14.04%
NTA ($)
-0.01
N/A
Dividend Yield
DPS ($)
-
Gross Div. Yield
-
Gross DPS ($)
-
Company Overview
Cryosite Limited (CTE) is a unique Australian biotech and biologics logistics company. The company's specialized biologics based services are grouped into two business lines - Cord Blood and Tissues Storage and Clinical Trials Logistics & Biorepository. Cryosite also provides specialized Bio-repository, Clinical Trials Logistics, Commercial Drug Distribution, contract Cellular Therapies manufacturing and associated consultancy services to commercial clients both within Australia and Internationally.
Former Names
--
Upcoming Calendar
| 25 Feb 2021 | Report (Interim) |
| 27 Aug 2021 | Report (Prelim) |
| 27 Aug 2021 | Report (Annual) |
Dividend History
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 14/03/2017 | $0.005 | 0% | Interim | 31/03/2017 |
| 07/09/2016 | $0.005 | 0% | Final | 04/10/2016 |
| 11/03/2016 | $0.005 | 0% | Interim | 31/03/2016 |
| 08/09/2015 | $0.005 | 0% | Final | 01/10/2015 |
| 13/03/2015 | $0.005 | 0% | Interim | 31/03/2015 |
| 08/09/2014 | $0.010 | 0% | Final | 24/09/2014 |
| 17/03/2014 | $0.005 | 0% | Interim | 04/04/2014 |
| 23/09/2013 | $0.010 | 0% | Final | 23/10/2013 |
| 18/03/2013 | $0.005 | 0% | Interim | 05/04/2013 |
See Upcoming Dividends for all ASX companies.
Announcements
| Date | Heading | Pages | File Size | Time |
|---|---|---|---|---|
Announcements provided by
Broker Consensus
The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". See the Consensus Data posts for more information.
CTE is not covered by a major broker,
or data from most recent compilation was omitted due
to not meeting QA guidelines.
Directors & Management
| Name | Title | Since | Bio |
|---|---|---|---|
| Mr Andrew John Kroger | Non-Executive Director | Nov 2011 |
|
| Mr Bryan Dulhunty | Company Secretary, Executive Chairman, Executive Director | Mar 2018 |
|
| Mrs Nicola Swift | Non-Executive Director | Nov 2016 |
|
Director Transactions
CTE directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
| Date | Director | Type | Amount | Price | Value | Notes |
|---|---|---|---|---|---|---|
| 17/04/20 | Andrew Kroger | Buy | +49,422 | $0.080 | $3,953 | On-market trade. |
| 06/04/20 | Andrew Kroger | Buy | +75,024 | $0.074 | $5,551 | On-market trade. |
| 13/03/20 | Andrew Kroger | Buy | +571,716 | $0.070 | $40,015 | On-market trade. |
| 09/03/20 | Andrew Kroger | Buy | +7,000 | $0.070 | $490 | On-market trade. |
| 04/03/20 | Andrew Kroger | Transfer | 713,590 | $0.070 | $49,951 | Off-market transfer. |
| 04/03/20 | Andrew Kroger | Buy | +371,159 | $0.067 | $24,872 | On-market trade. |
| 30/08/19 | Andrew Kroger | Buy | +500,000 | $0.057 | $28,500 | Off-market trade. |
| 04/07/19 | Bryan Dulhunty | Issued | 1,300,000 | $0.050 | $65,000 | Issue of options. |
| 22/03/18 | Andrew Kroger | Buy | +672,500 | $0.110 | $73,975 | Off-market trade. |
| 14/03/18 | Andrew Kroger | Buy | +625,885 | $0.110 | $68,547 | On-market trade. |
| 14/03/18 | Andrew Kroger | Transfer | 41,090 | $0.110 | $4,519 | Off-market transfer. |
| 09/10/17 | Stephen Roberts | Buy | +298,500 | $0.150 | $44,721 | On-market trade. |
| 30/06/17 | Andrew Kroger | Transfer | 41,090 | $0.160 | $6,574 | Off-market transfer. |
| 30/06/17 | Andrew Kroger | Buy | +1,327,500 | $0.190 | $252,225 | Off-market trade. |
| 30/06/17 | Andrew Kroger | Buy | +72,500 | $0.160 | $11,600 | On-market trade. |
| 03/01/17 | Stephen Roberts | Buy | +12,500 | $0.175 | $2,188 | On-market trade. |
| 14/12/16 | Stephen Roberts | Buy | +7,700 | $0.118 | $905 | |
| 14/12/16 | Stephen Roberts | Buy | +7,700 | $0.118 | $905 | On-market trade. |
| 07/12/16 | Stephen Roberts | Buy | +4,446 | $0.204 | $905 | |
| 31/08/16 | Andrew Kroger | Buy | +1,300,000 | $0.220 | $286,000 | |
| 30/06/16 | Andrew Kroger | Buy | +41,090 | $0.207 | $8,517 | |
| 30/11/15 | Graeme Moore | Expiry | 300,000 | $0.275 | $82,500 | |
| 24/11/15 | Andrew Kroger | Buy | +1,300,000 | $0.275 | $357,500 | |
| 08/09/15 | Christina (Christy) Boyce | Buy | +39,193 | $0.251 | $9,828 | |
| 02/03/15 | Christina (Christy) Boyce | Buy | +40,000 | $0.392 | $15,660 | |
| 02/03/15 | Andrew Kroger | Buy | +268,873 | $0.406 | $109,187 | |
| 09/09/13 | Andrew Kroger | Buy | +1,000,000 | $0.530 | $530,000 | |
| 25/06/13 | Christina Boyce | Buy | +38,941 | $0.430 | $16,763 | |
| 18/06/13 | Christina Boyce | Buy | +1,059 | $0.467 | $495 |
Shareholder Distribution
| Holding Size | 1 - 1,000 | 1,001 - 5,000 | 5,001 - 10,000 | 10,001 - 100,000 | 100,001 and over | Total Shareholders |
|---|---|---|---|---|---|---|
| No. of Shareholders | 38 | 217 | 61 | 100 | 41 | 457 |
Top 20 Shareholders
| Name | Shares | Capital |
|---|---|---|
| Andrew Kroger and related entities | 18,889,612 | 40.31% |
| Cell care Australia Pty Ltd | 9,129,995 | 19.48% |
| Bnp Paribas Nominees Pty Ltd | 2,087,384 | 4.45% |
| Mr. Alistair David Strong | 2,000,000 | 4.27% |
| Bell Potter Nominees Ltd | 1,758,236 | 3.75% |
| Mrs. Jane Susan Milliken | 1,302,917 | 2.78% |
| Mr. Stephen Roberts | 967,662 | 2.07% |
| Sunnyit Pty Ltd | 851,000 | 1.82% |
| H F A Administration Pty Limited | 480,000 | 1.02% |
| CVF Australia Pty Ltd | 459,085 | 0.98% |
| Paradyce Pty Ltd | 379,000 | 0.81% |
| Mr. Gary Griffith Robins | 325,000 | 0.69% |
| Castlereagh Equity Pty Ltd | 300,000 | 0.64% |
| Wifam Investments Pty Ltd | 300,000 | 0.64% |
| Integument Pty Ltd | 262,013 | 0.56% |
| Wheen Finance Pty Limited | 228,454 | 0.49% |
| Mr. Peter Howells | 215,730 | 0.46% |
| MNJ Holdings | 214,931 | 0.46% |
| Naron Nominees Pty Ltd | 213,007 | 0.45% |
| Mantou Republic Pty Ltd | 200,000 | 0.43% |
| All other shareholders | 13.44 % | |
The Top 20 Shareholders of CTE hold 86.56% of shares on issue.
CTE Share Price History
| Date | Close | Change | % Change | Open | High | Low | Volume | Turnover |
|---|---|---|---|---|---|---|---|---|
CTE Historical Data
Download up to 20 years of share price history.
| Year | Closing Price (30 June) | Last Trade |
|---|---|---|
| 2020 | $0.13 | 30 June |
| 2019 | $0.05 | 28 June |
| 2018 | $0.09 | 29 June |
| 2017 | $0.16 | 28 June |
| 2016 | $0.21 | 28 June |
| 2015 | $0.35 | 30 June |
| 2014 | $0.36 | 30 June |
Offical data as published by ASX. See more Data Downloads.
Company Details
Principal Activity: Provision of supply chain logistics, management of pharmaceutical products used in clinical trials, management of biological materials and long-term storage of cord blood and tissue samples.
Incorporated: in NSW in December 1999.
13a Ferndell St
South Granville NSW 2142
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.